Α-Hydroxyetizolam
Ọdịdị
Clinical data | |
---|---|
Other names | α-Hydroxyetizolam |
Dependence liability |
Moderate |
Routes of administration |
Oral, sublingual, rectal |
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 8.2 hours[1] |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | Page Templeeti:Plainlist/styles.css has no content. |
PubChem <abbr title="<nowiki>Compound ID</nowiki>">CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (<abbr title="<nowiki>U.S. Environmental Protection Agency</nowiki>">EPA) | |
Ihe omuma kemịkal na nke anụ ahụ | |
Nhazi | C17H15ClN4OS |
Ọkpụkpụ nke ọkpụkpụ | 358.84 g·mol-1 |
Ihe nlereanya 3D (JSmol) | |
Mmetụta ihere
| |
InChI
|
Etizolam's ọzọ na-abụghị pharmacologically na-arụ ọrụ metabolite na ụdị ke amụta site na ụmụ mmadụ bu 8-hydroxyetizolam.[2]
Hụkwa
[dezie | dezie ebe o si]
Ntụaka
[dezie | dezie ebe o si]- ↑ Fracasso, C.; Confalonieri, S.; Garattini, S.; Caccia, S. (1991-02-01). "Single and multiple dose pharmacokinetics of etizolam in healthy subjects". European Journal of Clinical Pharmacology. 40 (2): 181–185. doi:10.1007/BF00280074. ISSN 1432-1041. PMID 2065698. S2CID 10176681.
- ↑ PubChem. alpha-Hydroxyetizolam (en). pubchem.ncbi.nlm.nih.gov. Retrieved on 2021-02-23.